Black Rock Inc. Renovacor, Inc. Transaction History

Black Rock Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.12 - $2.18 $624 - $11,338	-5,201 Reduced 14.41%	30,896 $78,000
Q2 2022 Aug 12, 2022	BUY	$1.56 - $4.29 $55,348 - $152,209	35,480 Added 5750.41%	36,097 $73,000
Q4 2021 Feb 10, 2022	BUY	$6.99 - $9.39 $4,312 - $5,793	617 New	617 $5,000

Ticker RCOR
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,267,700
Description
Renovacor, Inc., a biotechnology company, focuses on delivering various precision therapies to enhance the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases. It primarily focuses on the treatment of BCL2-associated athanogene 3 (BAG3) mutation-associated dilated cardiomyopathy (DCM). T...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.